Researchers Tian, Wang, and Lu highlighted how third-generation sequencing technologies improve liver transplantation strategies for hepatocellular carcinoma (HCC). Their study emphasizes genomics-guided patient selection and post-transplant monitoring, aiming to enhance survival rates and reduce recurrence. Implementation of advanced sequencing facilitates precision medicine approaches in transplant oncology, underlining the trend of integrating molecular diagnostics to optimize treatment paradigms in liver cancer.